AstraZeneca Plc raised its annual forecast, driven by strong demand for its blockbuster cancer drugs, and revealed a plan to ...

J&J filed a lawsuit Tuesday in the US District Court for the District of Columbia alleging the US Health Resources and ...

In 2025, if the plan has a deductible, the $35 will not count towards that amount, but it will count towards the $2,000 ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study ... and business fronts,” said Stephen Brady, ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

"I am thrilled to further strengthen and enrich Ocular's senior leadership team with the appointment of Namrata as Chief ...

Unfortunately, this situation is becoming a more common reality with more than 900,000 Canadians working past the age of 65 ...

The Biosecurity Act, which prohibits US pharma companies from doing business with certain countries ... our supply chain will remain top priorities. FDA clearance for Goa was a major step and we plan ...